Conflict of Interest: Prof. Wöber-Bingöl, M. Tropeano, Prof. Karwautz, G. Wagner, S. Campos-de-Sousa, Dr. Zesch, Dr. Kienbacher, Dr. Natriashvili, Dr. Kanbur, Dr. Ray, and Prof. Collier report no disclosures. Prof. Wöber has received honoraria and travel funding from AstraZeneca (Austria), Linde Gas (Austria), A. Menarini Pharma GmbH (Austria), and Pfizer (Austria).
No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine
Article first published online: 11 MAR 2011
© 2011 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 51, Issue 5, pages 796–803, May 2011
How to Cite
Wöber-Bingöl, Ç., Tropeano, M., Karwautz, A., Wagner, G., Campos-de-Sousa, S., Zesch, H. E., Kienbacher, C., Natriashvili, S., Kanbur, I., Ray, M., Wöber, C. and Collier, D. A. (2011), No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine. Headache: The Journal of Head and Face Pain, 51: 796–803. doi: 10.1111/j.1526-4610.2011.01858.x
- Issue published online: 26 APR 2011
- Article first published online: 11 MAR 2011
- Accepted for publication January 7, 2011.
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!